Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 81Carcinoma, Non-Small-Cell Lung 41Colonic Neoplasms 40Lung Neoplasms 39Leukemia 36Rectal Neoplasms 34Lymphoma 34Colorectal Neoplasms 33Prostatic Neoplasms 24Multiple Myeloma 23Lymphoma, Follicular 22Leukemia, Myeloid, Acute 19Ovarian Neoplasms 18Lymphoma, Non-Hodgkin 18Leukemia, Lymphocytic, Chronic, B-Cell 18Lymphoma, Large B-Cell, Diffuse 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Melanoma 16Head and Neck Neoplasms 15Urinary Bladder Neoplasms 14Neoplasms, Plasma Cell 14Lymphoma, Large-Cell, Immunoblastic 14Burkitt Lymphoma 14Squamous Cell Carcinoma of Head and Neck 12Pancreatic Neoplasms 12Myelodysplastic Syndromes 12Leukemia, Myelomonocytic, Acute 12Leukemia, Monocytic, Acute 12Leukemia, Megakaryoblastic, Acute 12Leukemia, Erythroblastic, Acute 12

Interventions

Naloxone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × NIH × Intestinal Obstruction × Clear all
NCT00020605 2018-12-13

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain

National Cancer Institute (NCI)

Phase 3 Unknown
Other

Constipation, Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡